Adequate enrollment of women in cardiovascular drug trials and the need for sex-specific assessment and reporting.

Am Heart J Plus · 2022 · PMC10978324 · PMID 38559887

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

Pre-specified analysis of HPS2-THRIVE based on sex showed a trend towards worse CV outcomes in women treated with niacin ( p = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.